Each filer's latest filing for 010911105 since 12/18/2024, largest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Qiming Corporate GP VI, Ltd.
13G
|
10.2% |
8/11/2026
Event 6/30/2026
|
|
| Qiming Corporate GP VI, Ltd | 10.2% | ||
| Qiming Venture Partners VI, L.P. | 9.9% | ||
| Qiming Managing Directors Fund VI, L.P. | 0.3% | ||
| Qiming GP VIII, LLC | 2.3% | ||
| Qiming Venture Partners VIII Investments, LLC | 2.3% | ||
| Qiming GP VIII-HC, LLC | 2.8% | ||
| Qiming Venture Partners VIII-HC, L.P. | 2.8% | ||
|
Illumina Innovation Fund II, L.P.
13D
|
9.6% |
4/23/2026
Event 4/20/2026
|
|
| Illumina Innovation Fund II GP, L.L.C. | 8.8% | ||
| Illumina Innovation Fund II, L.P. | 8.8% | ||
| Illumina Innovation Fund III GP, L.L.C. | 0.8% | ||
| Illumina Innovation Fund III, L.P. | 0.8% | ||
| Nicholas Naclerio | 9.6% | ||
|
Sherpa Healthcare Fund II, L.P.
13G
|
7.2% |
7/2/2026
Event 4/16/2026
|
|
| Sherpa Healthcare Fund II, L.P. | 5.7% | ||
| Sherpa Healthcare Co-Investment Fund, L.P. | 1.4% | ||
| Sherpa Healthcare Fund II GP, Ltd. | 5.7% | ||
| Sherpa Healthcare Co-Investment GP Ltd. | 1.4% | ||
| Daqing Cai | 7.2% | ||
| Yuling Luo 13G | 6.4% |
8/13/2026
Event 6/30/2026
|
|
|
Sands Capital Life Sciences Pulse Fund II, L.P.
13D/A
|
6.1% |
7/7/2026
Event 7/5/2026
|
|
| Sands Capital Life Sciences Pulse Fund II, L.P. | 6.1% | ||
| Sands Capital Alternatives, LLC | 6.1% | ||
| Sands Frank M. | 6.1% |